High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia (Q34769839)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

anti-retroviral agent

0 references

0 references

1 reference

based on heuristic

inferred from title

Jean-François Delfraissy

11

object named as

Jean-François Delfraissy

0 references

12

object named as

Eric Nerrienet

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Laurent Ferradini

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Vara Ouk

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Olivier Segeral

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Janin Nouhin

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Anne Dulioust

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Chanroeurn Hak

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Isabelle Fournier

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Nathalie Lerolle

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sopheak Ngin

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Chhi Vun Mean

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jean-François Delfraissy

11

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

26 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Journal of the International AIDS Society

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

7 July 2018

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia

1 reference

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

Short Communication: Three Years Follow-Up of First-Line Antiretroviral Therapy in Cambodia: Negative Impact of Prior Antiretroviral Treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

26 October 2018

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

26 October 2018

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072300

26 October 2018

Adherence is not a barrier to successful antiretroviral therapy in South Africa

2 references

https://api.crossref.org/works/10.1186%2F1758-2652-14-14

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance after failure of initial antiretroviral therapy in resource-limited countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV Type 1 Isolates from 200 Untreated Individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase

1 reference

https://pubmed.ncbi.nlm.nih.gov/21439074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1758-2652-14-14

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34769839&oldid=2197023282"